Positron emission tomography (PET) can be used as a noninvasive method to longitudinally
monitor and quantify the expression of proteins in the brain in vivo. It can be used to monitor …

Neuroimaging with positron emission tomography (PET) is the most powerful tool for
understanding pharmacology, neurochemistry, and pathology in the living human brain. This …

Purpose Positron emission tomography (PET) is a widely used imaging technique with many
biomedical and drug development applications. The implementation of this technology …

Positron emission tomography (PET) allows non-invasive assessment of physiological,
metabolic and molecular processes in humans and animals in vivo. Advances in detector …

Neuroimaging studies with positron emission tomography (PET) have advanced our
understanding of the human brain by noninvasively assessing several aspects of cerebral …

Positron emission tomography (PET) is a non-invasive imaging technology employed to
describe metabolic, physiological, and biochemical processes in vivo. These include …

Positron emission tomography (PET) is used in the clinic and in vivo small animal research
to study certain molecular processes associated with diseases such as cancer, heart …

Studies on hereditary neurological disorders such as familial Alzheimer's disease (AD) have
revealed abnormalities of pathogenic proteins causative of neurodegeneration, while …

In this issue of Molecular Medicine, Irvine et al.(1) expound upon the application of
molecular biology in clinical medicine and the enabling of targeted interactions at a …

As drug discovery and development in Neuroscience push beyond symptom management
to disease modification, neuroimaging becomes a key area of translational research that …